• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA COVID-19 加强疫苗诱导的嗜酸性粒细胞丰富的线性 IgA 大疱性皮肤病。

Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.

机构信息

The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York, USA.

出版信息

J Cutan Pathol. 2023 Jan;50(1):24-28. doi: 10.1111/cup.14305. Epub 2022 Aug 23.

DOI:10.1111/cup.14305
PMID:35922892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9538274/
Abstract

We present a case of eosinophil-rich linear IgA bullous disease (LABD) following the administration of a messenger RNA COVID-19 booster vaccine. A 66-year-old man presented to the emergency department with a 3-week history of a pruritic blistering rash characterized by fluid-filled bullae and multiple annular and polycyclic plaques. He was initially diagnosed with bullous pemphigoid based on a biopsy showing a subepidermal blister with numerous eosinophils. However, direct immunofluorescence studies showed linear IgA and IgM deposition along the basement membrane zone with no immunoreactivity for C3 or IgG. Additionally, indirect immunofluorescence was positive for IgA basement membrane zone antibody. The patient was subsequently diagnosed with LABD and initiated on dapsone therapy with resolution of his lesions at 3-month follow-up. This case illustrates the growing number of autoimmune blistering adverse cutaneous reactions from vaccination. Dermatopathologists should be aware that features of autoimmune blistering diseases can overlap and may not be distinguishable based on these histopathological findings alone. Confirmation with direct immunofluorescence and/or serological studies may be necessary for accurate diagnosis.

摘要

我们报告了一例在接种信使 RNA COVID-19 加强疫苗后出现嗜酸性粒细胞丰富的线性 IgA 大疱性皮肤病 (LABD) 的病例。一名 66 岁男性因瘙痒性水疱性皮疹就诊于急诊科,该皮疹的特征为充满液体的大疱和多个环形和多环斑块。最初根据活检显示表皮下水疱伴大量嗜酸性粒细胞,诊断为大疱性类天疱疮。然而,直接免疫荧光研究显示沿基底膜带呈线性 IgA 和 IgM 沉积,C3 或 IgG 无免疫反应性。此外,间接免疫荧光 IgA 基底膜带抗体阳性。随后诊断为 LABD,并开始用氨苯砜治疗,在 3 个月随访时皮损得到缓解。该病例说明了越来越多的与疫苗接种相关的自身免疫性大疱性皮肤不良反应。皮肤科病理学家应该意识到,自身免疫性大疱性疾病的特征可能重叠,仅根据这些组织病理学发现可能无法区分。可能需要直接免疫荧光和/或血清学研究来进行准确诊断。

相似文献

1
Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.mRNA COVID-19 加强疫苗诱导的嗜酸性粒细胞丰富的线性 IgA 大疱性皮肤病。
J Cutan Pathol. 2023 Jan;50(1):24-28. doi: 10.1111/cup.14305. Epub 2022 Aug 23.
2
Flame figures in linear IgA bullous dermatosis: a novel histopathologic finding.线状IgA大疱性皮肤病中的火焰状图形:一项新的组织病理学发现。
Dermatol Online J. 2017 Nov 15;23(11):13030/qt1qs7m39f.
3
Linear IgA bullous dermatosis associated with immunotherapy.线性 IgA 大疱性皮病与免疫治疗相关。
Dermatol Online J. 2023 Dec 15;29(6). doi: 10.5070/D329662995.
4
Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time.短期内从线状免疫球蛋白A大疱性皮肤病转变为疱疹样天疱疮的病例。
J Dermatol. 2017 Feb;44(2):189-193. doi: 10.1111/1346-8138.13677. Epub 2016 Nov 5.
5
A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.一例可能并发疱疹样皮炎和线性 IgA/IgG 免疫球蛋白大疱性皮肤病。
Acta Dermatovenerol Croat. 2021 Jul;29(2):116-117.
6
Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.病例报告:结节性痒疹样线性 IgA/IgG 大疱性皮病:病例报告及文献复习。
Front Immunol. 2023 May 30;14:1201163. doi: 10.3389/fimmu.2023.1201163. eCollection 2023.
7
Linear IgA bullous dermatosis-a fifty year experience of Warsaw Center of bullous diseases.线状IgA大疱性皮肤病——华沙大疱性疾病中心五十年经验
Front Immunol. 2025 Jan 14;15:1478318. doi: 10.3389/fimmu.2024.1478318. eCollection 2024.
8
Linear IgA bullous dermatosis of childhood.儿童线状IgA大疱性皮肤病
Dermatol Online J. 2022 Oct 15;28(5). doi: 10.5070/D328559270.
9
A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence.采用直接免疫荧光法对基底膜带除 IgA 外无其他线性免疫球蛋白沉积的线性 IgA 大疱性皮肤病的临床和血清学研究。
Br J Dermatol. 2017 Jul;177(1):152-157. doi: 10.1111/bjd.15232. Epub 2017 Mar 22.
10
Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.线状IgA大疱性皮肤病。伴有IgA和IgG抗基底膜自身抗体的患者亚群的特征。
Arch Dermatol. 1995 Dec;131(12):1432-7. doi: 10.1001/archderm.131.12.1432.

引用本文的文献

1
Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.药物继发的线状IgA大疱性皮肤病:一项关于美国食品药品监督管理局不良事件报告系统的真实世界药物警戒研究
Front Med (Lausanne). 2025 Jan 23;12:1521697. doi: 10.3389/fmed.2025.1521697. eCollection 2025.
2
Linear IgA bullous dermatosis-a fifty year experience of Warsaw Center of bullous diseases.线状IgA大疱性皮肤病——华沙大疱性疾病中心五十年经验
Front Immunol. 2025 Jan 14;15:1478318. doi: 10.3389/fimmu.2024.1478318. eCollection 2024.
3
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.新冠疫苗接种后自身免疫性大疱性皮肤病的新发与加重:一项系统评价
Vaccines (Basel). 2024 Apr 26;12(5):465. doi: 10.3390/vaccines12050465.
4
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.新冠疫情期间的自身免疫性大疱性疾病:2022年利妥昔单抗与疫苗最新进展
Front Med (Lausanne). 2023 Jan 19;10:1112823. doi: 10.3389/fmed.2023.1112823. eCollection 2023.
5
Linear IgA bullous dermatosis after COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后线性IgA大疱性皮肤病
Int J Dermatol. 2023 Feb;62(2):e56-e58. doi: 10.1111/ijd.16541. Epub 2022 Dec 5.

本文引用的文献

1
Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.与新冠疫苗相关的大疱性类天疱疮:一项意大利多中心研究。
Front Med (Lausanne). 2022 Feb 28;9:841506. doi: 10.3389/fmed.2022.841506. eCollection 2022.
2
Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.COVID-19 及 COVID-19 疫苗接种背景下的玫瑰糠疹、玫瑰糠疹样发疹和带状疱疹。
Clin Dermatol. 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. Epub 2022 Jan 31.
3
Linear IGA bullous dermatosis potentially triggered by vaccination.线性 IgA 大疱性皮肤病可能由疫苗接种引发。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:20587384211021218. doi: 10.1177/20587384211021218.
4
Temporary exacerbation of pre-existing psoriasis and eczema in the context of COVID-19 messenger RNA booster vaccination: A case report and review of the literature.新型冠状病毒肺炎信使核糖核酸加强疫苗接种后原有银屑病和湿疹的暂时加重:一例病例报告及文献复习
JAAD Int. 2022 Mar;6:94-96. doi: 10.1016/j.jdin.2021.11.004. Epub 2021 Dec 18.
5
Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative.病例报告:婴儿大疱性类天疱疮:由新冠病毒引发只是推测。
Front Med (Lausanne). 2021 Nov 22;8:760823. doi: 10.3389/fmed.2021.760823. eCollection 2021.
6
Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.由新冠疫苗引发的大疱性类天疱疮:皮质类固醇治疗后迅速消退
Dermatol Ther. 2022 Jan;35(1):e15208. doi: 10.1111/dth.15208. Epub 2021 Nov 30.
7
Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine.接种牛津-阿斯利康 COVID-19 疫苗后发生线性 IgA 大疱性皮病。
Clin Exp Dermatol. 2022 Mar;47(3):611-613. doi: 10.1111/ced.15007. Epub 2021 Dec 8.
8
COVID-19 vaccines and skin manifestations.COVID-19 疫苗与皮肤表现。
Br J Dermatol. 2022 Jan;186(1):15. doi: 10.1111/bjd.20807. Epub 2021 Nov 2.
9
Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster.血管医学影像:新冠疫苗加强针接种后发生的白细胞破碎性血管炎
Vasc Med. 2022 Feb;27(1):100-101. doi: 10.1177/1358863X211055507. Epub 2021 Nov 1.
10
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.比较 COVID-19 疫苗在针对 SARS-CoV-2 及其关注变异株的特性、疗效和有效性方面的差异:一项叙述性综述。
Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.